Oncology Insights

This blog is designed for Fred Hutchinson Cancer Center referring providers who bring world-class cancer care to their patients. Gain timely insights from our nationally-renowned experts through our e-newsletter. We are privileged to partner with you.

Subscribe to Our E-Newsletter

Diagnosing and Managing Endocrine Immune-Related Adverse Events (irAEs)

Diagnosing and Managing Endocrine Immune-Related Adverse Events (irAEs)

Blog Posts - April 26, 2023

Fred Hutch Gynecologic Oncologists Seek to Collaborate with Community Physicians for Better Patient Outcomes

Fred Hutch Gynecologic Oncologists Seek to Collaborate with Community Physicians for Better Patient Outcomes

Blog Posts - March 22, 2023

Phase 1 clinical trials are an essential step in advancing the development of new cancer Therapies

Phase 1 clinical trials are an essential step in advancing the development of new cancer Therapies

Blog Posts - February 23, 2023

For the Latest Nuclear Medicine Therapies, Look to Fred Hutch

For the Latest Nuclear Medicine Therapies, Look to Fred Hutch

Blog Posts - February 16, 2023

Comprehensive prostate cancer focal therapy is now available at Fred Hutch

Comprehensive prostate cancer focal therapy is now available at Fred Hutch

Blog Posts - February 09, 2023

Precision radiation oncology is shifting the paradigm of cancer care

Precision radiation oncology is shifting the paradigm of cancer care

Blog Posts - February 02, 2023

Expert recommendations for treating metastatic non-small cell lung cancer

Expert recommendations for treating metastatic non-small cell lung cancer

Blog Posts - January 11, 2023

AML Review: Diagnosis, Treatment and What's New

AML Review: Diagnosis, Treatment and What's New

Blog Posts - December 27, 2022

Breast cancer vaccine safely generates anti-tumor immunity

Breast cancer vaccine safely generates anti-tumor immunity

Blog Posts - December 05, 2022

On-demand review course offers comprehensive update on solid tumors and hematologic disorders

On-demand review course offers comprehensive update on solid tumors and hematologic disorders

Blog Posts - December 01, 2022